The Scientist

» drug discovery, disease/medicine and evolution

Most Recent

image: Broadly Neutralizing Antibodies in HIV Patients

Broadly Neutralizing Antibodies in HIV Patients

By | September 28, 2016

Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies.

0 Comments

The National Institutes of Health is hosting a two-day conference on how the virus affects infants and children. The take-home message so far: microcephaly is but one of many potential problems for Zika-exposed fetuses.

0 Comments

image: How Plants Evolved Different Ways to Make Caffeine

How Plants Evolved Different Ways to Make Caffeine

By | September 21, 2016

Caffeine-producing plants use three different biochemical pathways and two different enzyme families to make the same molecule.

2 Comments

Scientists estimate the risk to fetuses exposed to the virus in utero.

0 Comments

Matching the immunological characteristics of donor retinal cells to those of the recipient can reduce the chance of rejection.

0 Comments

image: Stingrays Chew Too

Stingrays Chew Too

By | September 15, 2016

Researchers observe stingrays moving their jaws to grind up prey, a behavior thought to be restricted to mammals.

0 Comments

image: Neonatal Gut Bacteria Might Promote Asthma

Neonatal Gut Bacteria Might Promote Asthma

By | September 12, 2016

Byproducts of gut microbes in some 1-month–old babies trigger inflammation that is linked to later asthma development, researchers find.

1 Comment

image: Week in Review: September 5–9

Week in Review: September 5–9

By | September 9, 2016

Environmental magnetite in the human brain; prion structure takes shape; watching E. coli evolve in real time; learning from others’ behavior 

0 Comments

image: Giant Petri Dish Displays Evolution in Space and Time

Giant Petri Dish Displays Evolution in Space and Time

By | September 8, 2016

As E. coli bacteria spread over increasingly concentrated antibiotics, researchers discover novel evolutionary pathways that confer resistance.

7 Comments

image: Designing In Vitro Models of the Blood-Brain Barrier

Designing In Vitro Models of the Blood-Brain Barrier

By | September 1, 2016

Choosing the right model, be it 3-D or 2-D, requires wading through varied cell sources, cell types, and cell culture conditions.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS